Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity Via a SIRT1/p66Shc-Mediated Pathway

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2019 Dec 31

PMID 31885776

Citations 48

Authors

Yan-Zhao Wu

Lan Zhang

Zi-Xiao Wu

Tong-Tong Shan

Chen Xiong

Affiliations

Soon will be listed here.

Abstract

Doxorubicin- (DOX-) induced cardiotoxicity is associated with oxidative stress and cardiomyocyte apoptosis. The adaptor protein p66Shc regulates the cellular redox status and determines cell susceptibility to apoptosis. This study is aimed at investigating the involvement of sirtuin 1- (SIRT1-) mediated p66Shc inhibition in DOX-induced redox signalling and exploring the possible protective mechanisms of berberine (Ber) against DOX-triggered cardiac injury in rats and a cultured H9c2 cell line. Our results showed that the Ber pretreatment markedly increased CAT, SOD, and GSH-PX activities, decreased the levels of MDA, and improved the electrocardiogram and histopathological changes in the myocardium in DOX-treated rats (in vivo). Furthermore, Ber significantly ameliorated the DOX-induced oxidative insult and mitochondrial damage by adjusting the levels of intracellular ROS, ΔΨ, and [Ca] in H9c2 cells (in vitro). Importantly, the Ber pretreatment increased SIRT1 expression following DOX exposure but downregulated p66Shc. Consistent with the results demonstrating the SIRT1-mediated inhibition of p66Shc expression, the Ber pretreatment inhibited DOX-triggered cardiomyocyte apoptosis and mitochondrial dysfunction. After exposing H9c2 cells to DOX, the increased SIRT1 expression induced by Ber was abrogated by a SIRT1-specific inhibitor (EX527) or the use of siRNA against SIRT1. Accordingly, SIRT1 inhibition significantly abrogated the suppression of p66Shc expression and protection of Ber against DOX-induced oxidative stress and apoptosis. These results suggest that Ber protects the heart from DOX injury through SIRT1-mediated p66Shc suppression, offering a novel mechanism responsible for the protection of Ber against DOX-induced cardiomyopathy.

Citing Articles

Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and / experiments.

Yin B, Ren J, Liu X, Zhang Y, Zuo J, Wen R Front Pharmacol. 2025; 16:1524448.

PMID: 39906141 PMC: 11790656. DOI: 10.3389/fphar.2025.1524448.

The mechanism and therapeutic strategies in doxorubicin-induced cardiotoxicity: Role of programmed cell death.

Li Y, Yan J, Yang P Cell Stress Chaperones. 2024; 29(5):666-680.

PMID: 39343295 PMC: 11490929. DOI: 10.1016/j.cstres.2024.09.001.

Natural Products for Preventing and Managing Anthracycline-Induced Cardiotoxicity: A Comprehensive Review.

Szponar J, Nizinski P, Dudka J, Kasprzak-Drozd K, Oniszczuk A Cells. 2024; 13(13.

PMID: 38995002 PMC: 11240786. DOI: 10.3390/cells13131151.

Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis.

Metwally A, Ganguly S, Biomi N, Yao M, Elbayoumi T Molecules. 2024; 29(5).

PMID: 38474668 PMC: 10935258. DOI: 10.3390/molecules29051155.

Aqueous Extract Protects Cardiomyocytes against Doxorubicin-Induced Toxicity through Upregulation of NAD(P)H Dehydrogenase Quinone Acceptor Oxidoreductase 1.

Kim M, Choi H, Park S, Lee J, Lee J Molecules. 2023; 28(24).

PMID: 38138580 PMC: 10745630. DOI: 10.3390/molecules28248090.

References

Galimov E . The Role of p66shc in Oxidative Stress and Apoptosis. Acta Naturae. 2012; 2(4):44-51. PMC: 3347587. View

Tabeshpour J, Imenshahidi M, Hosseinzadeh H . A review of the effects of and its major component, berberine, in metabolic syndrome. Iran J Basic Med Sci. 2017; 20(5):557-568. PMC: 5478784. DOI: 10.22038/IJBMS.2017.8682. View

Ruan Y, Dong C, Patel J, Duan C, Wang X, Wu X . SIRT1 suppresses doxorubicin-induced cardiotoxicity by regulating the oxidative stress and p38MAPK pathways. Cell Physiol Biochem. 2015; 35(3):1116-24. DOI: 10.1159/000373937. View

Yan H, Jihong Y, Feng Z, Xiaomei X, Xiaohan Z, Guangzhi W . Sirtuin 1-mediated inhibition of p66shc expression alleviates liver ischemia/reperfusion injury. Crit Care Med. 2014; 42(5):e373-81. DOI: 10.1097/CCM.0000000000000246. View

Meng Z, Li J, Zhao H, Liu H, Zhang G, Wang L . Resveratrol relieves ischemia-induced oxidative stress in the hippocampus by activating SIRT1. Exp Ther Med. 2015; 10(2):525-530. PMC: 4509412. DOI: 10.3892/etm.2015.2555. View

Zhou S, Chen H, Wan Y, Zhang Q, Wei Y, Huang S . Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res. 2011; 109(6):639-48. DOI: 10.1161/CIRCRESAHA.111.243592. View

Yang Y, Duan W, Li Y, Yan J, Yi W, Liang Z . New role of silent information regulator 1 in cerebral ischemia. Neurobiol Aging. 2013; 34(12):2879-88. DOI: 10.1016/j.neurobiolaging.2013.06.008. View

Xiong C, Li J, Guo H, Zhang L, Guo W, Meng J . The H₁-H₂ domain of the α₁ isoform of Na+-K+-ATPase is involved in ouabain toxicity in rat ventricular myocytes. Toxicol Appl Pharmacol. 2012; 262(1):32-42. DOI: 10.1016/j.taap.2012.04.016. View

Sampaio S, Branco A, Wojtala A, Vega-Naredo I, Wieckowski M, Oliveira P . p66Shc signaling is involved in stress responses elicited by anthracycline treatment of rat cardiomyoblasts. Arch Toxicol. 2015; 90(7):1669-84. DOI: 10.1007/s00204-015-1583-9. View

10.

Ojha S, Al Taee H, Goyal S, Mahajan U, Patil C, Arya D . Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity. Oxid Med Cell Longev. 2016; 2016:5724973. PMC: 4893565. DOI: 10.1155/2016/5724973. View

11.

Alghamdi S, Leoncikas V, Plant K, Plant N . Synergistic interaction between lipid-loading and doxorubicin exposure in Huh7 hepatoma cells results in enhanced cytotoxicity and cellular oxidative stress: implications for acute and chronic care of obese cancer patients. Toxicol Res (Camb). 2016; 4(6):1479-1487. PMC: 4692330. DOI: 10.1039/c5tx00173k. View

12.

Sussman M . Mitochondrial integrity: preservation through Akt/Pim-1 kinase signaling in the cardiomyocyte. Expert Rev Cardiovasc Ther. 2009; 7(8):929-38. PMC: 4066730. DOI: 10.1586/erc.09.48. View

13.

Zhang Y, Sun J, Zhang Y, Chai Q, Zhang K, Ma H . The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial. Trials. 2016; 17(1):512. PMC: 5073878. DOI: 10.1186/s13063-016-1633-5. View

14.

Zhu X, Guo X, Mao G, Gao Z, Wang H, He Q . Hepatoprotection of berberine against hydrogen peroxide-induced apoptosis by upregulation of Sirtuin 1. Phytother Res. 2012; 27(3):417-21. DOI: 10.1002/ptr.4728. View

15.

Ming J, Xu S, Liu C, Liu X, Jia A, Ji Q . Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial. Trials. 2018; 19(1):72. PMC: 5787258. DOI: 10.1186/s13063-018-2438-5. View

16.

Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E . A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene. 2002; 21(24):3872-8. DOI: 10.1038/sj.onc.1205513. View

17.

Patil J, Kim J, Jayaprakasha G . Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol. 2010; 645(1-3):70-8. DOI: 10.1016/j.ejphar.2010.07.037. View

18.

Gomes A, Duarte F, Nunes P, Hubbard B, Teodoro J, Varela A . Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. Biochim Biophys Acta. 2011; 1822(2):185-95. PMC: 3366688. DOI: 10.1016/j.bbadis.2011.10.008. View

19.

Tan H, Chan K, Pusparajah P, Duangjai A, Saokaew S, Khan T . Rhizoma Coptidis: A Potential Cardiovascular Protective Agent. Front Pharmacol. 2016; 7:362. PMC: 5054023. DOI: 10.3389/fphar.2016.00362. View

20.

Singh P, Sharma R, McElhanon K, Allen C, Megyesi J, Benes H . Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radic Biol Med. 2015; 86:90-101. PMC: 4554811. DOI: 10.1016/j.freeradbiomed.2015.05.028. View